Translate the study need into a supply brief
A useful brief identifies the medicine, strength, dosage form, presentation and quantities required for the study. Include manufacturer preferences or product constraints where relevant. A non-confidential summary of the supply requirement is sufficient for the first conversation; participant information is not needed.
Discuss documentation and handling requirements
Study-specific requests may include particular documentation, expiry expectations or handling conditions. Set these out at the beginning so the proposed sourcing route can be assessed against the actual brief. Requirements are reviewed individually rather than assumed from the product name alone.
Plan around supply milestones
Share the first required date, destination markets and any anticipated staged requirements. These details help structure discussion of quantities, feasibility and next steps. TPA Pharma’s role here concerns commercial medicine supply enquiries; the clinical research team remains responsible for the study’s conduct.
What your trial supply enquiry should contain
- Product, strength, dosage form, presentation and manufacturer preferences
- Initial quantity and any expected later requirements
- Study destination markets and required supply milestones
- Documentation, expiry and handling requirements
Clinical supply questions
Do we need to send participant or patient information?
No. Please provide a non-confidential product and supply brief. Do not include participant identifiers, medical records or other personal health information in the contact form.
Can we discuss a staged supply requirement?
Yes. Outline the expected phases, quantities and dates in your enquiry. The feasibility of a particular schedule and any resulting commercial proposal must be assessed separately.
